MRI Interventions (MRIC) Stock Price, News & Analysis

Company Overview

MRI Interventions, Inc. is a medical technology company focused on providing magnetic resonance imaging (MRI)–guided therapy for minimally invasive neurosurgical procedures. The company’s core offering is the ClearPoint System, an integrated MRI-guided platform designed to enable real-time visualization and control during stereotactic neurosurgery. By combining advanced imaging hardware, proprietary software and procedural tools, MRI Interventions aims to improve the precision, safety and efficacy of neurosurgical treatments delivered in the MRI suite.

The ClearPoint System supports a variety of clinical applications, including deep brain stimulation lead placement, drug delivery for neurodegenerative diseases, biopsy and laser ablation. The system features MRI-compatible planning and navigation tools that allow surgeons to adjust their approach intra-procedure based on live imaging feedback. Workflows are designed to streamline procedural steps and reduce the need for patient transfers between operating rooms and imaging suites, potentially lowering overall procedure times and patient risks.

Founded in the early 2000s and headquartered in Irvine, California, MRI Interventions has expanded its commercial footprint to encompass leading academic medical centers and community hospitals across North America and Europe. The company has collaborated with key opinion leaders in neurosurgery and neuro-oncology to advance clinical validation, seeking to broaden the use of MRI-guided intervention in areas such as movement disorders, epilepsy and oncology. MRI Interventions continues to pursue regulatory approvals and strategic partnerships to support product adoption in new markets and indications.

Under the leadership of President and Chief Executive Officer Will Lewinski, the company emphasizes research and development to refine its imaging platforms and procedural instruments. The executive team combines expertise in medical device engineering, neuroscience and clinical care, striving to align product development with evolving standards in image-guided therapy. By advancing real-time MRI guidance, MRI Interventions positions itself at the intersection of innovation and patient-centric neurosurgical care.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 51,600 shs
• Average Volume: 63,036 shs
• Market Capitalization: $78.16 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

MRIC Stock Analysis - Frequently Asked Questions

How were MRI Interventions' earnings last quarter?

MRI Interventions Inc (OTCMKTS:MRIC) posted its earnings results on Tuesday, May, 15th. The company reported ($0.15) EPS for the quarter. The company earned $1.62 million during the quarter.

How do I buy shares of MRI Interventions?

Shares of MRIC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of MRI Interventions own?

Based on aggregate information from My MarketBeat watchlists, some other companies that MRI Interventions investors own include ClearPoint Neuro (CLPT), Pfizer (PFE), Consolidated Edison (ED), Gilead Sciences (GILD), Cheniere Energy (LNG), M&T Bank (MTB) and Occidental Petroleum (OXY).

Company Calendar

• Last Earnings: 5/15/2018
• Today: 7/12/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Medical Devices
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:MRIC
• CIK: 1285550
• Web: www.mriinterventions.com
• Phone: (949) 900-6833
• Fax: N/A
• Employees: 38
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 15,206,000
• Free Float: N/A
• Market Cap: $78.16 million
• Optionable: Not Optionable
• Beta: N/A